FFA
ZBH icon

Freedman Financial Associates’s Zimmer Biomet ZBH Stock Holding History

Freedman Financial Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20
Closed -$2K – 454
2022
Q1 		$2K Sell
20
-1
-5% -$121 ﹤0.01% 463
2021
Q4 		$3K Hold
21
– – ﹤0.01% 421
2021
Q3 		$3K Hold
21
– – ﹤0.01% 430
2021
Q2 		$3K Hold
21
– – ﹤0.01% 425
2021
Q1 		$3K Sell
21
-148
-88% -$22.9K ﹤0.01% 425
2020
Q4 		$25K Buy
+169
New +$23.9K 0.02% 271

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Freedman Financial Associates's ZBH Position: Q2 2022 in Review

Freedman Financial Associates sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 20 shares — an estimated $2K sold.

Freedman Financial Associates first reported a position in ZBH in Q4 2020 and held it in 6 quarters. The position peaked at $25K in Q4 2020. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Freedman Financial Associates reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 20 Zimmer Biomet shares in Q2 2022, an estimated $2K.
  • Freedman Financial Associates first reported a position in Zimmer Biomet in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Zimmer Biomet position peaked at $25K in Q4 2020.
  • 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.